secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001178913-25-001862
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward appoints Mark Grant as President and CEO, effective June 2, 2025
-------------------------------------------------------------------------

- Mark Grant will become CEO on June 2; Larry Jasinski serves as Co-CEO through June 30, then advisory through 2025.
- Grant received inducement option grant of 400,000 shares, vesting over 4 years, at closing price on grant date.
- Employment agreement includes $435,000 base salary, up to 70% annual bonus, and severance provisions.
- Grant brings 30 years of healthcare leadership, most recently as President of Americas at Medtronic and IMRA Surgical.
- Transition is planned; Jasinski will remain available on an as-needed basis through end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325001862/0001178913-25-001862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891325001862/zk2533212.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-001862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer